Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06202976 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06202976 · ClinicalTrials.gov record · last posted 2025-04-17

Mapping Epileptic Networks Using Multimodal Imaging

Study acronym: CREIM
StatusRecruiting
PhaseNot specified
Started2017-09-14
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Currently, mapping the epileptogenic zone is based on a comprehensive preoperative assessment involving clinical, imaging and electrophysiological examinations. To reduce the need for invasive stereoelectroencephalography (SEEG) explorations, electrophysiological and imaging methods have been developed, such as resting-state functional MRI (fMRI) coupled with electroencephalogram and arterial spin-labeling perfusion MRI (ASL-MRI). It has been published that these new methods enable precise delineation of the epileptogenic zone and better preparation for surgery. The aim is to determine whether, in children with focal lesional epilepsy, the combination of ASL-MRI-EEG and resting-state fMRI-EEG enables precise identification of the epileptogenic zone to be defined by SEEG, the current reference examination.

Amendment record 1 amendment on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended once since 2024-01-02. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

Trial Details
NCT Number NCT06202976
Lead Sponsor Imagine Institute
Conditions Epilepsy in Children
Enrollment 75 participants
Start Date 2017-09-14
Primary Completion 2033-09-13 (estimated)
Study Completion 2033-09-13 (estimated)
Updated on ClinicalTrials.gov 2025-04-17